{"prompt": "['Date and version No: FUTUREGB_Protocol_V6.0_19Jan2022.doc:', 'patients with gliomas involving pyramidal tracts. Neurosurgery 2007;61(5):935-48; discussion', '948-9.', '43) Ma R, Livermore LJ, Plaha P. Fast track recovery program after endoscopic and awake', 'intraparenchymal brain tumor surgery. World Neurosurg. 2016;93:246-52.', '44) Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I, Wijesekera O, Olivi A, Rahman M, et al. When', 'gross total resection of a glioblastoma is possible, how much resection should be achieved?', 'World Neurosurg. 2014;82(1-2):e257-65.', '45) Esquenazi Y, Friedman E, Liu Z, Zhu JJ, Hsu S, Tandon N. The survival advantage of \"supratotal\"', 'resection of glioblastoma using selective cortical mapping and the subpial technique.', 'Neurosurgery. 2017;81(2):275-88.', '46) Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on', 'survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg.', '2016;124(4):977-88', '47) Plaha P. et al. Functionally Guided Supramaximal resection of IDH Wild Type High grade glioma.', 'Abstract and Oral presentation. British Neuro Oncology Society Annual Meeting, Winchester, UK', '4-6th July 2018.', '48) Lau D, Hervey-Jumper SL, Chang S, Molinaro AM, McDermott MW, Phillips JJ, et al. A prospective', 'phase Il clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative', 'fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.', 'J Neurosurg. 2016;124(5):1300-9.', '49) Louis DN, Perry A, reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, et al. The', '2016 World Health Organization Classification of Tumours of the Central Nervous System: a', 'summary. Acta Neuropathol. 2016;131(6):803-20.', '50) McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical', 'innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374(9695):1105-12', '51) McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK, IDEAL Group. IDEAL framework for', 'surgical innovation 1: the idea and development stages. BMJ. 2013; 346:f3012.', '52) Biau DJ, Williams SM, Schlup MM, Nizard RS, Prorcher R. Quantitative and individualised', 'assessment of the learning curve using LC-CUSUM. B J Surg. 2008; 95(7):925-9.', '53) Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significant of changes in health-', 'related quality-of-life scores. J Clin Oncol. 1998;16(1):139-44.', '54) Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, et al. Influence of', 'treatment with tumour-treating fields on health-related quality of life of patients with newly', 'diagnosed glioblastoma:a secondary analysis of a randomized clinical trial. JAMA Oncol.', '2018;4(4):495-504.', '55) West HJ, Jin JO. Performance status in patients with cancer. JAMA Oncol. 2015;1(7)998.', 'Clinical Research Protocol Template version 14.0', 'Page 53 of 65', 'C Copyright: The University of Oxford and Oxford University Hospitals NHS Foundation Trust 2018', 'CONFIDENTIAL']['Date and version No: FUTUREGB_Protocol_V6.0_19Jan2022.doc:', '56) MoCA Montreal - Cognitive Assessment. (2019). MoCA Montreal - Cognitive Assessment. [online]', 'Viewed 18 October 2021.<https://www.mocatest.org/faq/>.', '57) Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-5.', '58) Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, et al. DELTA2 guidance on', 'choosing the target difference and undertaking and reporting the sample size calculation for a', 'randomised controlled trial. BMJ. 2018;363:k3570.', \"59) Philip A, Henshaw DL, Lamburn G, O'Carroll MJ. Brain tumours:rise in glioblastoma multiforme\", 'incidence in England 1995-2015 suggests an adverse environmental or lifestyle factor. Journal of', 'Environmental and Public Health 2018;article ID 7910754, 10 pages.', '60) David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, lan A Cree, Dominique Figarella-', 'Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger, Riccardo Soffietti,', 'Andreas von Deimling, David W Ellison, The 2021 WHO Classification of Tumors of the Central', 'Nervous System: a summary, Neuro-Oncology, Volume 23, Issue 8, August 2021, Pages 1231-', '1251', 'Clinical Research Protocol Template version 14.0', 'Page 54 of 65', 'C', 'Copyright: The University of Oxford and Oxford University Hospitals NHS Foundation Trust 2018', 'CONFIDENTIAL']\n\n###\n\n", "completion": "END"}